Geneoscopy Appoints Amit Bhalla as Chief Financial Officer to Advance Strategic Growth and Support Commercialization Efforts [Yahoo! Finance]
Becton, Dickinson and Company (BDX)
Last becton, dickinson and company earnings: 2/6 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bd.com
Company Research
Source: Yahoo! Finance
of gastrointestinal health, today announced the appointment of Amit Bhalla as Chief Financial Officer (CFO). Bhalla brings more than 25 years of experience in healthcare finance, strategy, and investment to support Geneoscopy's continued expansion, including the commercial launch of ColoSense®, the company's RNA-based, non-invasive colorectal cancer screening test. "Amit's extensive financial leadership and deep understanding of the healthcare landscape will be invaluable as we scale our operations and advance our mission of improving patient outcomes through innovative diagnostic solutions," said Andrew Barnell, Chief Executive Officer of Geneoscopy. "Following our recent $105 million Series C financing, Amit's expertise will be instrumental in optimizing our financial strategy as we continue our work to bring ColoSense to market and progress our pipeline of products for inflammatory bowel disease (IBD)." Bhalla most recently served as Executive Vice President and CFO at Sampled,
Show less
Read more
Impact Snapshot
Event Time:
BDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDX alerts
High impacting Becton, Dickinson and Company news events
Weekly update
A roundup of the hottest topics
BDX
News
- ??BD?????????????????????????????Science Connect Program???? [CNET News]CNET News
- BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow CytometryPR Newswire
- Becton, Dickinson and Company (NYSE:BDX) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.MarketBeat
- Is Becton Dickinson Now an Opportunity After Diagnostics Expansion and 2026 Business Separation Plans? [Yahoo! Finance]Yahoo! Finance
- BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest BiotecPR Newswire
BDX
Earnings
- 11/6/25 - Beat
BDX
Sec Filings
- 12/18/25 - Form ARS
- 12/18/25 - Form DEFA14A
- 12/18/25 - Form DEF
- BDX's page on the SEC website